WO2003021515A2 - Procede, appareil, et systeme pour la personnalisation d'huiles essentielles et d'autres formulations - Google Patents

Procede, appareil, et systeme pour la personnalisation d'huiles essentielles et d'autres formulations Download PDF

Info

Publication number
WO2003021515A2
WO2003021515A2 PCT/US2002/028719 US0228719W WO03021515A2 WO 2003021515 A2 WO2003021515 A2 WO 2003021515A2 US 0228719 W US0228719 W US 0228719W WO 03021515 A2 WO03021515 A2 WO 03021515A2
Authority
WO
WIPO (PCT)
Prior art keywords
analysis
essential oil
primary
extract
extracts
Prior art date
Application number
PCT/US2002/028719
Other languages
English (en)
Inventor
Cheryl Sott
Original Assignee
Cheryl Sott
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cheryl Sott filed Critical Cheryl Sott
Publication of WO2003021515A2 publication Critical patent/WO2003021515A2/fr

Links

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00Commerce
    • G06Q30/02Marketing; Price estimation or determination; Fundraising

Definitions

  • the present invention is directed to improvements in the treatment of persons by aromatherapy, improved essential oil formulations, improved methods ofmaking the formulations and products using the formulations.
  • Aromatherapy in one form or another has been around and has been practiced in one form or another since at least the dawn of civilization.
  • One school of thought traces aromatherapy to ancient Egypt.
  • a medical papyri has been found that is believed to date back to around 1550 BC which contains remedies for a number of illnesses and the methods of application are not unlike some ofthe ones used in aromatherapy today.
  • the Egyptians used a method known as infusion to extract the oils from aromatic plants and incense is an example of one ofthe earliest ways of using aromatics.
  • Frankincense was burned at sun rise as an offering to the sun god, Ra and myrrh was offered to the moon.
  • the Egyptians used aromatics in embalming to help preserve flesh.
  • the Egyptians also used fragrant oils after bathing either alone or accompanied by a massage.
  • Aromatherapy may be defined as the art, and science, of using oils extracted from aromatic plants to enhance health, beauty and overall wellness of an individual. These oils are known as essential oils. Apart from the physical benefits, it is believed that the essential oils can have subtle effects on the mind and emotions.
  • the essential oils taken from plants and used in aromatherapy are not only substances which gives the plants their scent but are considered by some to be the plant's "life force" i.e., they are essential to the plants' biological process.
  • the essential oils used in aromatherapy are extracted from flowers; herbs; spices; woods and fibers, usually by distillation, expression and solvent extraction.
  • Essential oils may be very expensive to produce, some more so than others, due to the labor intensive process and the quantity ofthe plant required to produce the oil, Approximately 400kg of thyme would produce 1kg of essential oil, 2000kg of rose petals to makelkg of oil , 6 tons of orange blossom to produce 1kg of neroli , and 4 million jasmine flowers to produce 1kg of jasmine absolute.
  • Essential oils have also been known as fragrance oils and are used in the fragrance industry, in their natural or synthetic form. Essential oils, contrary to the use ofthe word "oil” may not be really oily-feeling at all, rather, essential oil largely refers to the volatile component of plant material.
  • Aromatherapy uses the essential oils in a variety of ways.
  • One way is in a massage.
  • Some people consider the use ofthe oils in a massage to be the most effective method of using the oils, because the message combines their oils properties with the therapeutic power of touch.
  • the oils are usually not used undiluted, but are frequently combined with an odorless carrier oil, which may include, such oils as grapeseed, sweet almond or peach kernel.
  • the diluted solution may be about 3% essential oil.
  • Some essential oil constituent chemicals may be absorbed through the skin in small amounts but is believed that the amount is of therapeutic value.
  • Essential oils that are drawn into the body by the sense smell are believed to offer psychological and physical benefits; not only does the aroma ofthe true plant stimulate the brain to trigger a positive effect, but the natural components ofthe essential oil are drawn into the lungs and can also supply physical benefits also. Careful inhalation ofthe oils can also provide therapeutic benefit as the oil molecules enter the lungs and are absorbed into the bloodstream. If not done correctly and safely, however, the use of essential oils may also have negative consequences, in some circumstances.
  • the components ofthe various oils are believed to aid in a variety of health, beauty and hygiene conditions. Essential oils can supply other benefits as well. Some oils, for instance, act as a natural repellent and pesticide. Essential oils may be blended together to provide an especially pleasing fragrance and are also used to aid in providing a specific health benefit. A synergistic essential oil blend ofthe correct oils in proper proportions is considered to be greater in total benefit than each oil working independently.
  • the word chakra is a Sanskrit word meaning wheel or disk. Described as a wheel-like spinning vortex, a chakra is a point of intersection between various planes. The seven major centers along the spinal column have the greatest significance and the highest number of correlations in the treatment of chakras. These seven centers are thought of as the master chakras. Chakras are also called lotuses, symbolizing the unfolding of flower petals which metaphorically describe the opening of a chakra. Like flowers, chakras are believed to be opened or closed, dying or budding, depending on the consciousness within. Chakras are associated with seven basic levels of consciousness. The seven master chakra centers are identified as;
  • Chakra one located at the base ofthe spine, is associated with survival. Its element is earth.
  • Chakra two located in the lower abdomen is associated with emotions and sexuality. Its element is water.
  • Chakra three located in the solar plexus, is associated with personal power and metabolic energy. Its element is fire.
  • Chakra four located over the sternum, is associated with love. Its element is air.
  • Chakra six located in the center ofthe forehead, is associated with clairvoyance intuition and imagination. Its element is light.
  • Chakra seven located at the top ofthe head, is associated with knowledge and understanding. Its element is thought.
  • Various formulations are designed to address the treatment by aromatherapy ofthe various Chakras in a user.
  • the present invention is directed to a method of formulating customized aromatherapy, essential oil mixtures.
  • the method includes the steps of obtaining personality and preference information. This information is entered into the system. Based on the information provided personality responses are calculated to determine a personality value. From the personality value one or more essential oils may be excluded from Essential Oil Universe or Modified Essential Oil Universe, in view of certain conditions in the personality value and/or by name. Exclusionary conditions are obtained from the input of consumer information. If so indicated, certain essential oils, from Essential Oil Universe or Modified Essential Oil Universe, that represent adversity to that condition are excluded from the determination. If no oils or additional oils are to be excluded, the process proceeds. The identity of any additional exclusionary oil names, are obtained from input.
  • a Personality Sub-Set is created from step, and contains only oils associated with the given Personality Value.
  • a primary preference is determined.
  • the Personality Sub-Set is searched to satisfy the primary preference according to the ranking and an oil is selected. This oil is added to formulation and used to continue the process.
  • the Essential Oil Personality Sub-Set is searched for all oils that are related to the primary oil selected, to create the Primary Essential Oil Family Set.
  • a secondary preference is also obtained from input.
  • the Primary Essential Oil Family Set is searched to satisfy the secondary preference according to ranking and a second essential oil is selected.
  • the second selected oil is tested for exactness in name and fragrant "note” to other essential oil(s) that have previously been selected. If the second essential oil is not the same, that oil is confirmed, and placed in formulation. If the oil is the same, that oil is removed from Primary Essential Oil Family Set and then the process repeats itself at starting at the above steps, and for all subsequent preferences selected.
  • a formulation is created based on selected confirmed essential oil(s).
  • Figure 1 is a flow chart ofthe method ofthe preferred embodiment ofthe present invention for preparing a customized essential oil formula.
  • Figure 1 A is flow chart of the core process ofthe present invention.
  • Figure 2 is a flow chart ofthe essential oil universe modification process of the present invention.
  • Figure 3 is a flow chart ofthe essential oil exclusions process ofthe present invention.
  • Figure 4 is a flow chart ofthe "Chakra” essential oil selection process ofthe present invention.
  • Figure 5 is a flow chart ofthe oil selection test process ofthe present invention.
  • the system that can be utilized for the generation of essential oil formulations in accordance with one embodiment ofthe present invention can include a database containing data of essential oils. Such a database can be expressed in electronic media. There is also data received from the client. The data from the client is imported into CPU, which may, for example, comprise a central data processor with an associated system memory and standard peripherals. The CPU also has selectively addressable memory capable of storing digital data. The CPU may also be a network of computers linked together in a wide area network (WAN) or a local area network (LAN), combinations thereof, or one or more independent workstations. At the CPU, the data provided by the client is read and used with the database of essential oil data.
  • WAN wide area network
  • LAN local area network
  • an essential oil formulation As shown in Figure 1 the data concerning the customer is obtained from the customer. This data may be entered onto a form and then transferred to the system or the customer data may be directly entered into the system.
  • the data Alis preferably answers to personality and preference questions. Table A shows representative questions that may be asked of an intended user ofthe essential oils. Personality responses are calculated to determine a Personality Value A2. From the Personality Value an Essential Oil Subset A4 is created from the active essential oil universe A3. From the Essential Oil Subset A4 a primary essential oil is selected in accordance with primary preference determination A5 and ranking.
  • a related essential oil family set A7 is derived from the primary essential oil and, if indicated, a secondary preference A8 may be determined therefrom and a second essential oil is thus selected.
  • the tertiary preference is determined and a third essential oil is selected A9. Additional essential oils may be determined in the same manner if desired. Once the identity or identities ofthe essential oil or oils has been determined, a preferred formulation output A10 and oil ratios are determined. Once the oil ratios are determined, the essential oil formulation Al 1 is created. The formulation may be displayed A12 on a screen or printed out, etc. Once an essential oil formulation is created, the formulation may be analyzed and a decision made A13 to either repeat the process to come up with a new formulation, or save the formulation and/or if desired to print the formulation.
  • the formulation will contain one or more essential oils and can be used either by itself as a fragrance or it may be combined with one or more base materials and be used as a massage oil, lotion, salve, unguent, etc.
  • the oils may also be included in a cosmetic formulation, bath or body oil, face cream, hand lotion etc., depending on the user's choice.
  • a Personality & Preference Profile 1 A is generated for a user.
  • a Personality Analysis and Evaluation Calculation A2 is made and from that an essential oil subset is obtained.
  • a primary preference A5 is determined and an oil A6 is selected in accordance with the ranking so obtained.
  • an oil A6 is selected in accordance with the ranking so obtained.
  • a related essential family oil set A7 is generated.
  • a secondary preference A8 may be determined and from that a second essential oil is selected A8a.
  • a tertiary preference and subsequent essential oils may be selected in the same manner.
  • Based on the information so obtained a preferred formulation output is obtained and oil ratios are determined A10. Once the oil ratios are determined an essential oil formulation Al 1 may be created using the information so generated.
  • Figure 2 shows a flow chart where there is the essential oil universe.
  • the universe may be modified Bl by a user selecting or deselecting a desired oil or oils from the universe.
  • the remaining essential oil universe is the modified essential oil universe B2.
  • the personality & preference profile Al undergoes an exclusionary analysis CI with the profile being tested C2 for exclusionary conditions such as allergies, among others. If there are no exclusionary conditions, no essential oils are excluded from the essential oil ' universe, so that the modified universe C2b is actually not modified and becomes active A3. If there are exclusionary conditions present, the essential oil universe may have additional essential oils excluded C2a forming a modified universe.
  • the modified universe excluding such oils so formed becomes the active essential oil universe A3. It is additionally possible that essential oils may be excluded by name Z, obtained from input. If indicated the oils identified by name are excluded from the modified universe Zl, forming the active universe. If no oils are indicated by name, no essential oils are excluded from the modified universe and thus becomes the active essential oil universe A3.
  • FIG. 4 depicts the "Chaka" essential oil selection process ofthe present invention.
  • the exclusionary analysis is performed as is a Chaka Analysis and Valuation Calculation Dl may also be performed.
  • a Chaka Analysis and Valuation Calculation Dl From this calculation a Primary "Chakra” Oil in the Chakra Universe is obtained and the Active Essential Oil Universe is searched to confirm the active status of th Chakra oil selected. If the Chakra oil is not active an alternative oil is selected.
  • Figure 5 shows the oil selection test process noted above.
  • an. oil that has been selected A8a from the' primary essential oil family set A7 is tested.
  • a determination is made El whether the oil has the same name as any ofthe other oil(s) selected and confirmed. If so, that oil is excluded from the Family set. If the oil does not have the same name as the other oils selected and confirmed a further analysis may be made to ascertain whether the oil has the same "Note” as the others selected and confirmed. If so, that oil is excluded from the Family Set. If not, then the oil is selected and confirmed and the process continues by selecting any additional essential oils if desired.
  • a user wishes to receive a customized essential oil formulation a series of questions similar to the questions shown in Table A are asked.
  • the results from the questionnaire are inputted into the system.
  • the personality profile responses are given a value which may be a numerical designation and where a numerical designation, the value can either be a single number or a range.
  • a first cut ofthe essential oils is made (primary essential oil set). After a first cut is made by the system two other pieces of information are taken into consideration. These are the focus condition and the actual condition in the focus condition group that are chosen by the user. Based on the actual condition in the focus condition group. The first or primary essential oil is selected.
  • oils selected from the primary essential oil family set are tested to determine if they are identical to the primary oil and if so that oil is not accepted and a another is selected in its place.
  • Question 6 in the Personality Profile may be used where the treatment of Chakra' s is desired.
  • the response to this question identifies the Chakra that is to be treated.
  • the Chakra oil or oils are selected by the system and the user may receive an essential oil formulation to treat just the Charka or the user may also answer the remaining questions and receive a formulation as described above that may be combined with the essential oil or oils in the Chakra formulation.
  • the Chakra oil is the same as one ofthe primary, secondary, tertiary or other oils
  • the Chakra essential oil is added to the formulation unlike the situation described above.
  • Essential Oils in the Essential Oil Universe may include but are not limited to any one ofthe following natural or synthetic oils identified by their common or botanical names or variations of those names and blends thereof: Ajowan - Trachyspermum Ammi,
  • Each ofthe essential oils has certain properties and other characteristics that make it advantageous for certain treatments.
  • An example of a chart showing information concerning, a representative oil is Table B.
  • a customer desirous of obtaining an essential formulation has personality and preference information Al is entered into the system. Based on the information provided personality responses are calculated to determine a personality value A2. From the personality value one or more essential oils may be excluded from Essential Oil Universe or Modified Essential Oil Universe, in view of certain conditions in the personality value and/or by name Cl . Exclusionary conditions C2 are obtained from input of consumer information. If so indicated, all essential oils, from Essential Oil Universe or Modified Essential Oil Universe that represent adversity to that condition are excluded from the determination C2a. If no oils or additional oils are to be excluded, the process proceeds, C2b. The exclusionary process may also include a process Z, where oils may be excluded (suspended) from the modified essential oil universe, for the active formulation only.
  • any additional exclusionary oil names are obtained directly from input Z by name. If the presence ofthe oil is indicated, then any oil with that name from Essential Oil Universe or Modified Essential Oil Universe is excluded, Zl forming the active xmiverse, A3. The remaining essential oils make up the Active Essential Oil Universe , and this universe is filtered A3 for all oils for the given Personality Value.
  • a Personality Sub-Set A4 is created from step A3, and contains only oils associated with the given Personality Value.
  • a primary preference A5 is determined from input.
  • the Personality Sub-Set A4 is searched to satisfy the primary preference according to the ranking and an oil is selected A6. This oil is added to formulation and used to continue the process.
  • the Essential Oil Personality Sub-Set A7 is searched for all oils that are related to the primary oil selected in A6, to create the Primary Essential Oil Family Set.
  • a secondary preference A8 is also determined from input.
  • the Primary Essential Oil Family Set is searched A7 to satisfy the secondary preference according to ranking and a second essential oil is selected A8a.
  • the second selected oil is tested for exactness in name El and fragrant "note” E2 to other essential oils that have previously been selected and confirmed. If the second essential oil is not the same, that oil is confirmed A9, and placed in formulation. If the oil is the same E3, that oil is removed from Primary Essential Oil Family Set A7 and then the process repeats itself at starting at A8, for all subsequent preferences determined, and oil(s) selected, hi the process of the present invention the preferred output is determined from the user input.
  • a Chakra value is calculated from input D2.
  • the Chakra universe is searched D3 for a value.
  • a Chakra oil is selected D4.
  • the Active Essential Oil Universe is searched to confirm active status of the Chakra oil so selected D5. If the Chakra oil is not active D6a, alternate chakra oil is selected. If so the Chakra essential oil is active the selection D6b is confirmed. All oils selected are formatted Al 1 for desired output.
  • the formulation determined is displayed A12.
  • the formulation may be recalculated. If so the process goes to step Al where information input is still active A13a.
  • the formulation may be saved to a client archive A13a.
  • the formulation may also be printed A13b.
  • the essential oil universe in a way that is semi-permanent in nature. If so one or more oils in the essential oil universe may be selected for exclusion from the process Bl, for example by un-checking its check box in an oil inventory feature The unchecked oils will not be used in the above process until check box is checked and therefore activated.
  • formulations may have containing one or more essential oils, botanical extracts, herbal extracts, flavor extracts and nutritional supplements and/or combinations thereof and be formed by the methods set forth above.
  • Botanical extracts are sometimes used interchangeably with the term herbal extracts. These extracts are usually a product derived from a natural botanical source including sources derived from the sea. The product may be derived from the whole plant or from its parts, stems, leaves, flower for example. The product derived from the plant material may come in various forms including tablets, capsules, softgels, gelcaps, liquids, or powders. Botanical extracts may include but are not limited to the following:
  • Herbal extracts can include but are not limited to the following:
  • Flavor Extracts are typically natural or artificially produced flavoring products that may affect the sense of taste or alter the taste of a particular product. Flavor extracts may come in a variety of forms with liquid and powder being the most popular. Examples of Flavor extract can include the replication ofthe taste of fruits, vegetables, candy products or any of a multitude of other substance that would affect the sense of taste. Flavor extracts may include but are not limited to the following:
  • Nutritional Supplements also known as Dietary Supplements are any of various organic substances that can be essential to animal nutrition, and may include vitamins, enzymes, coenzymes, amino acids or minerals. These supplements may come is a variety of forms including tablets, capsules, softgels, gelcaps, liquids, or powders. Examples of some nutritional supplements are as follows:
  • ALA Alpha Lipoic Acid
  • BCAAs Branched-Chain Amino Acids
  • HCA Hydroxycitric Acid
  • Linoleic Acid Conjugated

Landscapes

  • Business, Economics & Management (AREA)
  • Engineering & Computer Science (AREA)
  • Accounting & Taxation (AREA)
  • Development Economics (AREA)
  • Strategic Management (AREA)
  • Finance (AREA)
  • Game Theory and Decision Science (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Economics (AREA)
  • Marketing (AREA)
  • Physics & Mathematics (AREA)
  • General Business, Economics & Management (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Cosmetics (AREA)
PCT/US2002/028719 2001-08-30 2002-08-29 Procede, appareil, et systeme pour la personnalisation d'huiles essentielles et d'autres formulations WO2003021515A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94337001 2001-08-30
US09/943,372 2001-08-30

Publications (1)

Publication Number Publication Date
WO2003021515A2 true WO2003021515A2 (fr) 2003-03-13

Family

ID=25479534

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/028719 WO2003021515A2 (fr) 2001-08-30 2002-08-29 Procede, appareil, et systeme pour la personnalisation d'huiles essentielles et d'autres formulations

Country Status (1)

Country Link
WO (1) WO2003021515A2 (fr)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894483A1 (fr) * 2005-12-13 2007-06-15 Deylon Sarl Composition cosmetique a base d'huiles et leurs utilisations dans le soulagement des douleurs.
EP1841505A1 (fr) * 2004-12-24 2007-10-10 Dolphst Pty Ltd Formulations et traitements destines au bien-etre
US8357418B2 (en) 2006-09-04 2013-01-22 Barry Callebaut Ag Method for preparing chocolates and/or chocolate-/cocoa-flavored compositions
CN103141531A (zh) * 2013-03-07 2013-06-12 马氏兄弟科技(北京)股份有限公司 一种复方植物精油及其应用
AU2012202194B2 (en) * 2004-12-24 2014-04-24 Dolphst Pty Ltd. Formulations and treatments for well-being
WO2014145086A2 (fr) * 2013-03-15 2014-09-18 Galvez Alfredo Flores Produits et méthodes utilisant des mélanges à base d'extrait de soja enrichi en lunasine pour réduire des niveaux d'acide gras libre, augmenter des niveaux de leptine et augmenter des niveaux d'adiponectine du plasma
US9468659B2 (en) 2014-11-06 2016-10-18 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
WO2017007833A1 (fr) * 2015-07-06 2017-01-12 George Marc Compléments sains
US9980993B2 (en) 2014-11-06 2018-05-29 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
CN108713641A (zh) * 2018-05-08 2018-10-30 广东海洋大学 一种壳聚糖季铵盐和中草药复合饲料添加剂及其制备方法和应用
CN110200203A (zh) * 2019-04-29 2019-09-06 浙江野麦实业有限公司 一种具有降糖功效的燕麦米及其制备方法
CN110368468A (zh) * 2019-08-29 2019-10-25 无限极(中国)有限公司 一种具有抗污染损伤作用的组合物及制备方法、应用
WO2021046396A1 (fr) * 2019-09-04 2021-03-11 Amare Global Suppléments nutritionnels et procédés de supplémentation nutritionnelle affectant l'humeur et la mise au point chez les enfants
US11529387B2 (en) 2019-09-04 2022-12-20 Amare Global Nutritional supplements and methods of nutritional supplementation affecting global mood state
US11723941B2 (en) 2019-09-04 2023-08-15 Amare Global Nutritional supplements and methods of supplementation affecting the endocannabinoid system

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012202194B2 (en) * 2004-12-24 2014-04-24 Dolphst Pty Ltd. Formulations and treatments for well-being
EP1841505A1 (fr) * 2004-12-24 2007-10-10 Dolphst Pty Ltd Formulations et traitements destines au bien-etre
EP1841505A4 (fr) * 2004-12-24 2010-01-27 Dolphst Pty Ltd Formulations et traitements destines au bien-etre
EP2491938A1 (fr) * 2004-12-24 2012-08-29 Dolphst Pty Ltd Formulations destinés au bien-être
US8475849B2 (en) 2004-12-24 2013-07-02 Dolphst Pty Ltd. Formulations and treatments for well-being
FR2894483A1 (fr) * 2005-12-13 2007-06-15 Deylon Sarl Composition cosmetique a base d'huiles et leurs utilisations dans le soulagement des douleurs.
US8357418B2 (en) 2006-09-04 2013-01-22 Barry Callebaut Ag Method for preparing chocolates and/or chocolate-/cocoa-flavored compositions
CN103141531B (zh) * 2013-03-07 2015-02-25 马氏兄弟科技(北京)股份有限公司 一种复方植物精油及其应用
CN103141531A (zh) * 2013-03-07 2013-06-12 马氏兄弟科技(北京)股份有限公司 一种复方植物精油及其应用
WO2014145086A3 (fr) * 2013-03-15 2014-11-27 Galvez Alfredo Flores Produits et méthodes utilisant des mélanges à base d'extrait de soja enrichi en lunasine pour réduire des niveaux d'acide gras libre, augmenter des niveaux de leptine et augmenter des niveaux d'adiponectine du plasma
WO2014145086A2 (fr) * 2013-03-15 2014-09-18 Galvez Alfredo Flores Produits et méthodes utilisant des mélanges à base d'extrait de soja enrichi en lunasine pour réduire des niveaux d'acide gras libre, augmenter des niveaux de leptine et augmenter des niveaux d'adiponectine du plasma
US9468659B2 (en) 2014-11-06 2016-10-18 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
US9980993B2 (en) 2014-11-06 2018-05-29 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
US11369655B2 (en) 2015-07-06 2022-06-28 Cg-Bio Genomics, Inc. Healthful supplements
WO2017007833A1 (fr) * 2015-07-06 2017-01-12 George Marc Compléments sains
CN108713641A (zh) * 2018-05-08 2018-10-30 广东海洋大学 一种壳聚糖季铵盐和中草药复合饲料添加剂及其制备方法和应用
CN110200203A (zh) * 2019-04-29 2019-09-06 浙江野麦实业有限公司 一种具有降糖功效的燕麦米及其制备方法
CN110368468A (zh) * 2019-08-29 2019-10-25 无限极(中国)有限公司 一种具有抗污染损伤作用的组合物及制备方法、应用
WO2021046396A1 (fr) * 2019-09-04 2021-03-11 Amare Global Suppléments nutritionnels et procédés de supplémentation nutritionnelle affectant l'humeur et la mise au point chez les enfants
US11529386B2 (en) 2019-09-04 2022-12-20 Amare Global Nutritional supplements and methods of nutritional supplementation affecting mood and focus in children
US11529387B2 (en) 2019-09-04 2022-12-20 Amare Global Nutritional supplements and methods of nutritional supplementation affecting global mood state
US11723941B2 (en) 2019-09-04 2023-08-15 Amare Global Nutritional supplements and methods of supplementation affecting the endocannabinoid system

Similar Documents

Publication Publication Date Title
WO2003021515A2 (fr) Procede, appareil, et systeme pour la personnalisation d'huiles essentielles et d'autres formulations
Nwosu et al. Nutraceuticals: history, classification and market demand
Rajat et al. Nutraceuticals: A review
Yaniv et al. Handbook of medicinal plants
Kumar et al. Promising therapeutics with natural bioactive compounds for improving learning and memory—a review of randomized trials
Prabu et al. Nutraceuticals: A review
Cavaliere et al. Herbal Supplement sales rise in all channels in 2009.
US11395840B2 (en) Enhanced herb or food product and method
Morgovan et al. Nutrivigilance: A new activity in the field of dietary supplements
Cong et al. Immune-boosting functional foods: A potential remedy for Chinese consumers living under polluted air
Domarew et al. A study of Russian phytomedicine and commonly used herbal remedies
CN1994357A (zh) 蓝莓与蜂胶配伍的提高免疫力的组合物
Specter Miracle in a bottle
Israelsen Phytomedicines: the greening of modern medicine
Allkanjari et al. A descriptive study of commercial herbal dietary supplements used for dyslipidemia—Sales data and suspected adverse reactions
Marzec et al. Dietary supplements as a challenge for contemporary public health: scale of the phenomenon, health risk, legal regulations
Cassileth PDQ integrative oncology: complementary therapies in cancer care
Kar Nutraceuticals in Pharmaceutical Field
Sen et al. Challenges for Incorporation of Nutraceuticals in Food
Puranik et al. Recent Facts and Global Perspectives of Nutraceuticals in Medicine
Choudhary et al. Regulatory Aspects of Global Nutraceuticals and Functional Foods for the Utilization of Fruits–An Insight
Rao et al. Formulations, Regulations, and Challenges of Nutraceuticals
Hall et al. Exploring Adaptogens’
Tutelyan et al. The Legislative Regulation of Biologically Active Food Supplements Circulation in the Russian Federation
Alisa et al. Effects of oral administration of aqueous extract of kuding leaves on the weight and packed cell volume (PCV) of wistar albino rats

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP